The Valley Desk

NCT02401048 · Interventional trial

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas

Overall registry status Completed

Phase 1 · Phase 2

Conditions Diffuse Large B-Cell Lymphoma, Follicular Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov